Sen-Jam initiates subject enrolment in Phase II Covid-19 treatment trial
Sen-Jam Pharmaceutical has initiated subject enrolment in the Phase II trial of its investigational oral Covid-19 therapy, SJP-002C, in Nepal.
Source: clinicaltrialsarena.com
Page 2 - Jam Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jam Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jam Pharmaceutical Today - Breaking & Trending Today
Sen-Jam Pharmaceutical Opens Enrollment for Patients in Their COVID Therapy Phase 2 Clinical Trial in Nepal and Engages With Strategic Investor for Worldwide Distribution
Sen-Jam Pharmaceutical has cleared the various regulatory hurdles and now is actively enrolling patients in it's much anticipated COVID oral therapeutic...
Source: prnewswire.com
KVK Tech Announces Phase II Trial of COVID-19 Oral Therapy is Currently Enrolling in Nepal
/PRNewswire/ -- Sen-Jam Pharmaceuticals and KVK Tech are collaborating to develop a Covid-19 oral therapy. The companies will operate in parallel while they...
Source: prnewswire.com
Sen-Jam and KVK Tech collaborate to develop Covid-19 oral therapy
Sen-Jam Pharmaceutical has entered a collaboration with KVK Tech to develop, manufacture, supply and licence Covid-19 oral treatment.
Source: pharmaceutical-technology.com
Sen-Jam Pharmaceutical Partners with Specialty Pharmaceutical Manufacturer to Provide Formulation and Chemistry, Manufacturing & Controls for Covid-19 Oral Therapeutic
/PRNewswire/ -- Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing...
Source: prnewswire.com